Aarti Drugs' Sayakha Plant Operations Resume Post GPCB Order Revocation

Aarti Drugs Ltd has announced the revocation of a closure order issued by the Gujarat Pollution Control Board (GPCB) for its Amines manufacturing operations at the Sayakha plant in Bharuch, Gujarat. The revocation is effective from July 31, 2026.

Reader Takeaway: Operational continuity restored; minor ₹10.2 lakh environmental compensation paid.

What just happened

The GPCB had previously issued a closure directive for the company's Sayakha plant following an inspection on June 20, 2026. The inspection identified non-compliances related to environmental regulations, specifically concerning the Water Act of 1974 and Consolidated Consents and Authorization (CCA) conditions. Aarti Drugs applied for revocation, which has now been accepted by the GPCB, allowing operations to continue.

Why this matters

This development is crucial for Aarti Drugs as it removes the immediate threat of operational disruption at its Sayakha facility. The plant's Amines manufacturing operations are now cleared to proceed, ensuring business continuity. While a penalty of ₹10.2 lakh was paid as interim environmental damage compensation under the 'Polluter Pays' principle, the company's management has confirmed no material impact on its overall financial or business activities.

The backstory

The GPCB's initial closure order stemmed from observations made during an inspection on June 20, 2026, at the plant located in the Saykha Industrial Estate, Bharuch. Non-compliance with environmental norms led to the directive.

What changes now

With the revocation order effective July 31, 2026, the Amines manufacturing operations at the Sayakha plant can resume normal functioning. Aarti Drugs has also deposited the interim environmental damage compensation of ₹10.2 lakh.

Risks to watch

While the immediate regulatory hurdle has been cleared, investors will be keen to see management's progress on implementing corrective and preventive measures. Ensuring sustained compliance with environmental norms will be key to preventing future disruptions.

Peer comparison

Companies in the chemical and pharmaceutical sectors frequently face scrutiny regarding environmental compliance. Aarti Drugs' situation highlights the importance of robust environmental management systems in this industry.

Context metrics (time-bound)

The closure order was issued after an inspection on June 20, 2026, and the revocation is effective July 31, 2026. A penalty of ₹10.2 lakh was paid.

What to track next

Investors should track the company's future disclosures on its environmental compliance initiatives and any further communication from the GPCB.